GSK 494581A, with the CAS number 909416-67-7, is a chemical compound that has been investigated primarily for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain protein kinases involved in various cellular processes, including cell proliferation and survival. The compound is part of a broader class of kinase inhibitors that are being explored for their efficacy in treating diseases such as cancer and autoimmune disorders. GSK 494581A exhibits characteristics typical of kinase inhibitors, including the ability to modulate signaling pathways that are often dysregulated in disease states. Its chemical structure includes functional groups that facilitate binding to the target kinase, thereby inhibiting its activity. Research into GSK 494581A has focused on its pharmacokinetics, bioavailability, and safety profile, which are crucial for determining its viability as a therapeutic agent. Overall, GSK 494581A represents a promising candidate in the field of medicinal chemistry, particularly in the development of targeted therapies.

GSK494581A is a both a glycine transporter subtype 1 inhibitor and GPR55 agonist.

GSK 494581A

909416-67-7: GSK 494581A, with the CAS number 909416-67-7, is a chemical compound that has been investigated primarily for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain protein kinases involved in various cellular processes, including cell proliferation and survival. The compound is part of a broader class of kinase inhibitors that are being explored for their efficacy in treating diseases such as cancer and autoimmune disorders. GSK 494581A exhibits characteristics typical of kinase inhibitors, including the ability to modulate signaling pathways that are often dysregulated in disease states. Its chemical structure includes functional groups that facilitate binding to the target kinase, thereby inhibiting its activity. Research into GSK 494581A has focused on its pharmacokinetics, bioavailability, and safety profile, which are crucial for determining its viability as a therapeutic agent. Overall, GSK 494581A represents a promising candidate in the field of medicinal chemistry, particularly in the development of targeted therapies.

GSK494581A is a GPR55 agonist and glycine transporter subtype 1 inhibitor.

CAS 909416-67-7

GSK 494581A

GSK494581A

Ref: TM-T27480